As per the agreement, NSE-listed Vaishali Pharma Limited will take over the entire domestic and international marketing of Jark Pharma’s portfolio of quality based ayurvedic products
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
The company will set-up a pharmaceuticals formulation manufacturing unit with an investment of Rs. 100 crore in Odisha
The acquired brands are well established and recognized among doctors and other members of the medical fraternity in Brazil for their reliability, safety, and trustworthiness
Government of India has granted a patent for invention entitled "An improved safe process for the preparation of Sartan drugs of Formula I".
The company had responded to the agency and carried out the required corrective actions.
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
Within the API segment, ~20% of the revenues came from the domestic market and ~80% from the exports market
Q2 FY23 business performance has been slow primarily due to lower volume offtake from pharmaceutical manufacturers
Subscribe To Our Newsletter & Stay Updated
